Variant report

Variant	rs72994452
Chromosome Location	chr3:142857313-142857314
allele	C/T
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type
1	chr3:142847512..142849517-chr3:142856776..142858672,2	K562	blood:
2	chr3:142851820..142854133-chr3:142856452..142858967,2	MCF-7	breast:
3	chr3:142850270..142855258-chr3:142857254..142859835,5	K562	blood:
4	chr3:142841738..142844491-chr3:142857167..142859995,2	K562	blood:
5	chr3:142854742..142857547-chr3:142861968..142864216,2	K562	blood:

Variant related genes	Relation type
ENSG00000241679	Chromatin interaction

Extended variants
information (count: 7 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:2)

rs_ID	r²[population]
rs59144348	0.95[AFR][1000 genomes];1.00[AMR][1000 genomes]
rs61315190	0.95[AFR][1000 genomes];1.00[AMR][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:5 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	esv2757893	chr3:142720230-142962932	Enhancers Active TSS Flanking Active TSS Strong transcription Flanking Bivalent TSS/Enh Weak transcription Bivalent/Poised TSS Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	20 gene(s)	inside rSNPs	diseases
2	esv2759183	chr3:142720230-142964373	Strong transcription Weak transcription Enhancers Bivalent Enhancer Active TSS Genic enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	20 gene(s)	inside rSNPs	diseases
3	nsv949288	chr3:142793323-143585882	Enhancers Flanking Active TSS Weak transcription ZNF genes & repeats Strong transcription Active TSS Transcr. at gene 5' and 3' Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	24 gene(s)	inside rSNPs	diseases
4	nsv1007164	chr3:142837004-142891719	Flanking Active TSS Weak transcription ZNF genes & repeats Bivalent/Poised TSS Enhancers Active TSS Flanking Bivalent TSS/Enh Strong transcription Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	10 gene(s)	inside rSNPs	diseases
5	nsv508250	chr3:142842454-142943722	Enhancers Weak transcription Flanking Active TSS Active TSS Genic enhancers Bivalent Enhancer ZNF genes & repeats Bivalent/Poised TSS Strong transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	6 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:31 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr3:142841200-142858000	Weak transcription	Spleen	Spleen
2	chr3:142844800-142858200	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
3	chr3:142845800-142858200	Weak transcription	Fetal Brain Male	brain
4	chr3:142853400-142870600	Weak transcription	Primary T cells from cord blood	blood
5	chr3:142853600-142873000	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
6	chr3:142853800-142858400	Weak transcription	K562	blood
7	chr3:142854400-142858400	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
8	chr3:142854600-142858400	Weak transcription	Psoas Muscle	Psoas
9	chr3:142854800-142857800	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
10	chr3:142854800-142857800	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
11	chr3:142854800-142858000	Weak transcription	Fetal Brain Female	brain
12	chr3:142854800-142858400	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
13	chr3:142854800-142865800	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
14	chr3:142855000-142857400	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
15	chr3:142855000-142857400	Weak transcription	Fetal Lung	lung
16	chr3:142855000-142858000	Weak transcription	ES-I3 Cell Line	embryonic stem cell
17	chr3:142855000-142858400	Weak transcription	Cortex derived primary cultured neurospheres	brain
18	chr3:142855000-142858600	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
19	chr3:142855000-142858600	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
20	chr3:142855000-142858600	Weak transcription	HMEC	breast
21	chr3:142855000-142858600	Weak transcription	NHEK	skin
22	chr3:142855000-142858600	Weak transcription	Osteobl	bone
23	chr3:142855200-142857800	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
24	chr3:142855600-142857800	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
25	chr3:142855600-142858000	Weak transcription	NHLF	lung
26	chr3:142855600-142858200	Weak transcription	HUVEC	blood vessel
27	chr3:142856600-142858600	Enhancers	Dnd41	blood
28	chr3:142856600-142859600	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
29	chr3:142857000-142857400	Enhancers	Primary monocytes fromperipheralblood	blood
30	chr3:142857200-142857400	Enhancers	Monocytes-CD14+_RO01746	blood
31	chr3:142857200-142857600	Enhancers	Liver	Liver

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links